Overview

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

Status:
Terminated
Trial end date:
2001-02-22
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study the effectiveness of chemotherapy plus bone marrow transplantation in treating patients with metastatic melanoma that has not responded to previous therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Feist-Weiller Cancer Center at Louisiana State University Health Sciences
Louisiana State University Health Sciences Center Shreveport
Treatments:
Busulfan
Cyclophosphamide
Cyclosporine
Cyclosporins
Methotrexate